吉利德科学 逆市拉升，创下历史新高。消息面上，吉利德科学公布去年第四季度业绩，营收同比增长5%至79亿美元，超过分析师预期的77亿美元；调整后每股收益为1.86美元，亦超过预期的1.81美元。期内，艾滋病相关产品销售额同比增长6%至58亿美元，主要受艾滋病预防和治疗需求增加推动。
吉利德科学 逆市拉升，创下历史新高。消息面上，吉利德科学公布去年第四季度业绩，营收同比增长5%至79亿美元，超过分析师预期的77亿美元；调整后每股收益为1.86美元，亦超过预期的1.81美元。期内，艾滋病相关产品销售额同比增长6%至58亿美元，主要受艾滋病预防和治疗需求增加推动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
